MedTrace Logo

ICON8: Weekly Chemotherapy in Ovarian Cancer

NCT01654146 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1485

Last updated 2012-07-31

No results posted yet for this study

Summary

The purpose of this study is to determine if weekly chemotherapy (i.e. giving paclitaxel or carboplatin at a lower dose every week) is more effective than standard chemotherapy (paclitaxel and carboplatin given once every three weeks over 18 weeks) in treating ovarian cancer. The investigators also want to see if weekly chemotherapy causes more or fewer side-effects than standard chemotherapy.

Conditions

Interventions

DRUG

Carboplatin

AUC5 by intravenous infusion over 30-60 minutes

DRUG

Carboplatin

AUC2 by intravenous infusion over 30-60 minutes

DRUG

Paclitaxel

175mg/m2 by intravenous infusion over 3 hours

DRUG

Paclitaxel

80mg/m2 by intravenous infusion over 1 hour

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2017-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01654146 on ClinicalTrials.gov